NRx Pharmaceuticals and TMS are undergoing various reviews with the FDA, including guidance on real-world evidence and a ketamine ANDA review.

The entities involved

• FDA →
  • HHS policy allows peptides in compounding pharmacies despite FDA lack of approval, with RFK Jr. arguing for safer compounds.08:58
  • HHS policy changes regarding peptide access are affecting Olympia's facility.08:58
• TMS →

  American metadata company

  • The Labour Party and TMS entered a formal alliance to support Bola Ahmed Tinubu's economic and structural reforms.Sun 18:59
  • DMI announced an alliance with TMS on October 24, 2026.Sun 01:08

Related events

• FDA approved a medical device from Abbott and supported a PARADIGM study based on data from the Cleveland Clinic.Wed 21:06
• A company is conducting clinical trials and seeking drug approval for the U.S. market under the FDA.Jun 7
• FDA provided guidance for HCW Biologics' IND application.Oct 9
• Litigation regarding FDA approval process.Sep 2
• Arthur Caplan questioned the FDA regarding the status of clinical trials in 2006.Oct 22